Sino Biopharmaceutical Ltd (SBMFF)
0.43
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Sino Biopharmaceutical Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2021 | 1.101B |
March 31, 2021 | 1.116B |
December 31, 2020 | 832.73M |
September 30, 2020 | 791.16M |
June 30, 2020 | 906.20M |
March 31, 2020 | 891.17M |
December 31, 2019 | 697.50M |
September 30, 2019 | 968.25M |
June 30, 2019 | 926.30M |
March 31, 2019 | 919.57M |
December 31, 2018 | 745.97M |
September 30, 2018 | 882.35M |
June 30, 2018 | 796.37M |
March 31, 2018 | 731.24M |
December 31, 2017 | 509.94M |
September 30, 2017 | 594.53M |
June 30, 2017 | 527.66M |
March 31, 2017 | 560.51M |
December 31, 2016 | 448.66M |
September 30, 2016 | 552.24M |
June 30, 2016 | 499.08M |
March 31, 2016 | 536.08M |
Date | Value |
---|---|
December 31, 2015 | 436.15M |
September 30, 2015 | 544.75M |
June 30, 2015 | 479.16M |
March 31, 2015 | 479.24M |
December 31, 2014 | 430.55M |
September 30, 2014 | 406.13M |
June 30, 2014 | 387.18M |
March 31, 2014 | 382.36M |
December 31, 2013 | 307.96M |
September 30, 2013 | 340.32M |
June 30, 2013 | 315.03M |
March 31, 2013 | 294.93M |
December 31, 2012 | 250.51M |
September 30, 2012 | 247.06M |
June 30, 2012 | 227.55M |
March 31, 2012 | 230.36M |
December 31, 2011 | 174.48M |
September 30, 2011 | 205.18M |
June 30, 2011 | 185.46M |
March 31, 2011 | 158.46M |
June 30, 2010 | 129.13M |
March 31, 2010 | 116.95M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
697.50M
Minimum
Dec 2019
1.116B
Maximum
Mar 2021
905.09M
Average
891.17M
Median
Mar 2020
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
Enterprise Value | 8.600B |
Earnings Yield | 3.94% |
Operating Earnings Yield | 10.54% |
Normalized Earnings Yield | 3.884 |